Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01418703 · ClinicalTrials.gov registry record · NA

Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT01418703: Completed NA study, sponsored by University of Virginia.

NCT01418703 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01418703, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

In this protocol the investigators plan to demonstrate the feasibility of a modular insulin management system based on continuous glucose monitoring and targeted towards the avoidance of hypoglycemic and prolonged hyperglycemic episodes (i.e. control to range). The protocol is designed to challenge the insulin management system with meals and mild exercise, so as to demonstrate its capacity to avoid large glucose excursion with changing metabolic state. This system is designed to both * monitor the meal boluses of the patient and correct it in case of observed/predicted under insulinization (avoidance of prolonged hyperglycemia), based on a coarse and subjective knowledge of the meal amount, a precise understanding of the subject's day to day insulin treatment, continuous glucose monitoring, and past insulin injections; * predict and avoid hypoglycemic events, based on continuous glucose reading and past insulin injection. The investigators plan to enroll 12 adult Type 1 Diabetes Mellitus (T1DM) patients (expected retention 10/12) and compare glucose control performances under two treatments: standard vs. the new insulin management system. The protocol will include a total of 6 admissions per subject (4 out-patients and 2 in-patients): screening, effort test, CGM insertion 1, inpatient 1, CGM insertion 2, and inpatient 2. During the 24h inpatient admissions, the patients will be challenged with 30 minutes of mild exercise and 3 meals, insulin coverage of these events will vary depending on the chosen treatment, each subject will be exposed to both studied treatments (repeated measure design).The order of treatment during the inpatient admissions will be randomized.

Primary Outcome

Number of hypoglycemic events below 70 mg/dL per patient per day

Interventions

  • DEVICE Closed Loop Control (CLC)
  • DEVICE Open Loop

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2009-10
Est. Completion 2010-12
Phase NA
University of Virginia

449 total trials

What the finished NCT01418703 record still lists

NCT01418703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Closed Loop Control (CLC) is the first listed.

NCT01418703 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01418703 about?

NCT01418703 is a clinical study titled "Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus". In this protocol the investigators plan to demonstrate the feasibility of a modular insulin management system based on continuous glucose monitoring and targeted towards the avoidance of hypoglycemic and prolonged hyperglycemic episodes (i.e. control to range). The protocol is designed to challenge ...

What is the current status of trial NCT01418703?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2009-10. Estimated completion is 2010-12.

What interventions are being tested in trial NCT01418703?

The interventions under investigation include: Closed Loop Control (CLC) (DEVICE), Open Loop (DEVICE).

Who is sponsoring clinical trial NCT01418703?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01418703's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01418703, the US trial registry maintained by the National Library of Medicine. NCT01418703 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.